Gilead Sciences

Associate Director- Clinical Site Partner (Inflammation)

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates should possess strong therapeutic and technical expertise to engage in scientific discussions with investigators and site personnel. They must be able to establish and maintain professional relationships with investigator sites, develop strategies for concierge-level support, and track key performance metrics. Experience in establishing and managing partnerships with local Patient Advocacy Groups (PAGs) and communities is also required. The role necessitates identifying investigator sites, PAGs, and communities that align with portfolio strategy and priorities to expand Gilead's clinical research partnership network.

Responsibilities

The Associate Director- Clinical Site Partner will optimize the delivery of clinical trial programs by establishing and maintaining strong relationships with investigator sites, leveraging disease area expertise. They will develop strategies to provide exceptional support to preferred sites, aiming to make Gilead the Sponsor of Choice. Responsibilities include tracking site performance metrics for continuous improvement, managing partnerships with local PAGs and communities for protocol development and study design input, and serving as an internal resource to champion the patient perspective. The role involves sharing pipeline information with investigators and communities, collecting field intelligence on the competitive landscape, and supporting study teams and CROs to ensure timely trial delivery from initiation to closeout. This includes assisting with feasibility, site recommendations, initiation visits, and facilitating communication to overcome enrollment barriers. Additionally, the Associate Director will support the development and implementation of site risk plans to meet study milestones and act as a local escalation point for investigator sites, partnering to resolve issues and remove barriers to clinical trial execution.

Skills

Clinical Trial Management
Investigator Site Relationships
Disease Area Expertise
Performance Metrics Tracking
Patient Advocacy Groups
Collaboration
Communication

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI